SUNEVA MEDICAL RAISES $35.4 MILLION IN CAPITAL FOR ONGOING PRODUCT COMMERCIALIZATION EFFORTS AND EXPANSION OF BUSINESS DEVELOPMENT ACTIVITIES

Financing includes $15 million in a Series C equity investment from Almirall, Inc., an affiliate of Almirall, S.A and a $20.4 million growth-capital term loan from an account managed by HealthCare Royalty Partners Capital to support continuing commercialization of company’s aesthetic product portfolio Company will expand its business development and licensing activities to enhance its …

SUNEVA MEDICAL RAISES $35.4 MILLION IN CAPITAL FOR ONGOING PRODUCT COMMERCIALIZATION EFFORTS AND EXPANSION OF BUSINESS DEVELOPMENT ACTIVITIES Read More »